GlassScriptPhysician profile
Matthew Hodge
NPI 1801084207
$6,340.49
in general payments reported to CMS, 2019-2025
26 companies · $1,330 in 2025
The $1,330 reported for 2025 was more than what 93% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $923 · 2022: $1,355 · 2023: $1,088 · 2024: $1,644 · 2025: $1,330.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,062.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,062.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,142.16 | 2021-2025 | Emblem Mri S-Icd, Lux-Dx Insertable Cardiac Monitor, S-Icd System Magnet |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $799.88 | 2021-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $388.35 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $209.67 | 2022-2025 | Camzyos, Eliquis |
| Inari Medical, INC. | $153.21 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Astrazeneca Pharmaceuticals LP | $63.26 | 2021-2025 | Wainua |
| Stryker Corporation | $63.17 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Abiomed | $51.31 | 2024 | Impella |
| Irhythm Technologies, INC. | $48.51 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Janssen Pharmaceuticals, INC | $44.28 | 2022 | |
| Getinge USA Sales, LLC | $41.95 | 2024 | Vasoview Hemopro 2 |
| Atricure, INC. | $39.08 | 2022 | |
| Biosense Webster, INC. | $34.87 | 2025 | Carto 3 |
| Bridgebio Pharma, INC. | $32.89 | 2025 | Attruby |
| Medtronic, INC. | $29.98 | 2021-2024 | Cobalt Dr Mri Surescan |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $28.50 | 2025 | Injectafer |
| Angiodynamics, INC. | $27.87 | 2023 | Angiovac |
| Novo Nordisk INC | $19.42 | 2022 | |
| Shockwave Medical, INC | $17.88 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Impulse Dynamics (USA) INC. | $17.07 | 2024 | Optimizer |
| Abbott Laboratories | $16.46 | 2023 | Diamondback Coronary |
| Pfizer INC. | $16.20 | 2023 | |
| Sanofi-Aventis U.S. LLC | $15.30 | 2023 | |
| Cardiovascular Systems INC. | $14.75 | 2023 | Diamondback Coronary |
| Baxter Healthcare | $12.71 | 2021 | |
| Altathera Pharmaceuticals LLC | $11.76 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Hodge listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.